The youths had not sought the information earlier, but now that vaccination has been opened for the 18-44 age group, they need the details...

The price cut followed widespread criticism as Bharat Biotech had sold it to the central government at Rs 150 per dose...

Company says it is ‘deeply concerned’ with the critical pandemic circumstances in India...

The government now supplies doses to healthcare centres which will end on April 30...

Both are available at a rate of Rs 150 per dose to the central government...

It is twice the corresponding price tag on Covishield, the AstraZeneca vaccine produced in the country by the Serum Institute of India...

Only three to four persons per 10,000 inoculated were affected by the coronavirus after two doses...

More than 5,500 contracted coronavirus after receiving second jab, says Centre...

Bharat Biotech vaccine 70 per cent efficient in asymptomatic patients according to interim analysis results...

Covaxin production ramped up to 700 million doses per annum...